Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10383820 | SCILEX PHARMS | Colchicine drug-to-drug interactions |
Nov, 2036
(12 years from now) | |
US10383821 | SCILEX PHARMS | Colchicine drug-to-drug interactions |
Nov, 2036
(12 years from now) | |
US9907751 | SCILEX PHARMS | Composition and method of use of colchicine oral liquid |
Nov, 2036
(12 years from now) | |
US10226423 | SCILEX PHARMS | Colchicine drug-to-drug interactions |
Dec, 2037
(13 years from now) |
Drugs and Companies using COLCHICINE ingredient
Market Authorisation Date: 30 January, 2019
Treatment: A method of prophylactic treatment of gout flares in adults comprises administering to a patient a liquid colchicine oral solution
Dosage: SOLUTION;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9925264 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) | |
US11786455 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) | |
US11793766 | SCILEX PHARMS | Non-aqueous patch for the relief of pain |
May, 2031
(6 years from now) | |
US10765749 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) | |
US9931403 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) | |
US11278623 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) | |
US10765640 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) | |
US9283174 | SCILEX PHARMS | Non-aqueous patch |
May, 2031
(6 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product(NP) | Feb 28, 2021 |
Drugs and Companies using LIDOCAINE ingredient
Market Authorisation Date: 28 February, 2018
Treatment: Method for relieving the pain associated with post-herpetic neuralgia
Dosage: PATCH;TOPICAL